THR-ARG-SER-ALA-TRP
CAS138949-73-2
THR-ARG-SER-ALA-TRP (CAS 138949-73-2, C27H41 N9 O8) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.
- CAS No.
- 138949-73-2
- Formula
- C27H41 N9 O8
- Mol. weight
- 619.67 g/mol
Chemical Specifications
Identifiers
| CAS number | 138949-73-2 |
|---|---|
| Product name | THR-ARG-SER-ALA-TRP |
| Chinese name | 人体甲状腺激素相关肽 |
| Synonyms | HYPERCALCEMIA OF MALIGNANCY FACTOR (107-111) (HUMAN, BOVINE, DOG, HORSE, MOUSE, RABBIT, RAT) |
| Chinese synonyms | 人体甲状腺激素相关肽; LYS-HIS-LEU-ASN-SER-MET-GLU-ARG-VAL-GLU-TRP-LEU-ARG-LYS-LYS-LEU-GLN-ASP-VAL-HIS-ASN-PHE: KHLNSMERVEWLRKKLQDVHNF |
| Molecular formula | C27H41 N9 O8 |
| Molecular weight | 619.67 g/mol |
Packaging, Storage & Transport
| Available pack sizes | 5kg, 1kg, 500g, 100g, 50g, 10g |
|---|
Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.
Frequently Asked Questions
What is the CAS number of THR-ARG-SER-ALA-TRP?
The CAS Registry Number of THR-ARG-SER-ALA-TRP is 138949-73-2. THR-ARG-SER-ALA-TRP is also known as HYPERCALCEMIA OF MALIGNANCY FACTOR (107-111) (HUMAN, BOVINE, DOG, HORSE, MOUSE, RABBIT, RAT).
What is the molecular formula and molecular weight of THR-ARG-SER-ALA-TRP?
The molecular formula of THR-ARG-SER-ALA-TRP is C27H41 N9 O8, and its molecular weight is 619.67 g/mol.
How can I request a quotation for THR-ARG-SER-ALA-TRP?
Send an inquiry for THR-ARG-SER-ALA-TRP (CAS 138949-73-2) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.
Request a Quote for THR-ARG-SER-ALA-TRP
Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.
Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.